4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-21-000117
Director sold 63,131 shares at an average $44.43 ($2,805,197)
- Director gave 300,000 shares (gift)
- Director gave 300,000 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
Tessier-Lavigne Marc · Director
Table I: Non-derivative
16 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-10-04 | Gift : show line 1 in the form | −300,000 | 2,244,370 | D | ||
| 2021-10-04 | Gift : show line 2 in the form | +100,000 | 100,000 | I | ||
| 2021-12-28 | Sale : show line 3 in the form | −3,732 | $44.37 | $165,589 | 96,268 | I |
| 2021-12-29 | Sale : show line 4 in the form | −10,700 | $43.88 | $469,516 | 85,568 | I |
| 2021-12-30 | Sale : show line 5 in the form | −3,343 | $45.13 | $150,870 | 82,225 | I |
| 2021-12-30 | Sale : show line 6 in the form | −3,377 | $45.59 | $153,957 | 78,848 | I |
| 2021-10-04 | Gift : show line 7 in the form | +100,000 | 100,000 | I | ||
| 2021-12-28 | Sale : show line 8 in the form | −3,602 | $44.38 | $159,857 | 96,398 | I |
| Open-market sales · 63,131 sh · avg $44.43 · $2,805,197 | ||||||
Loading xslF345X03/wf-form4_164091956763788.xml…